Challenges in pediatric post-sepsis care in resource limited settings: a narrative review.

Sepsis infection low- and middle-income country (LMIC) pediatrics post-discharge mortality

Journal

Translational pediatrics
ISSN: 2224-4344
Titre abrégé: Transl Pediatr
Pays: China
ID NLM: 101649179

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 14 11 2020
accepted: 23 04 2021
entrez: 12 11 2021
pubmed: 13 11 2021
medline: 13 11 2021
Statut: ppublish

Résumé

The objective of this narrative review is to outline the current epidemiology and interventional research within the context of sepsis recovery, and to provide a summary of key priorities for future work in this area. Morbidity and mortality secondary to sepsis disproportionately affects children, especially those in low- and middle-income countries (LMICs), where over 85% of global cases and deaths occur. These regions are plagued by poorly resilient health systems, widespread socio-economic deprivation and unique vulnerabilities such as malnutrition. Reducing the overall burden of sepsis will require a multi-pronged strategy that addresses all three important periods along the sepsis care continuum - pre-facility, facility and post-facility. Of these aspects, post-facility issues have been largely neglected in research, practice and policy, and are thus the focus of this review. Relevant data for this review was identified through a literature search using PubMed, through a review of the citations of select systematic reviews and from the personal repositories of articles collected by the authors. Data is presented within three sections. The first two sections on the short and long-term outcomes among sepsis survivors each outline the epidemiology as well as review relevant interventional research done. Where clear gaps exist, these are stated. The third section focuses on priorities for future research. This section highlights the importance of data (and data systems) and of innovative interventional approaches, as key areas to improve research of post-sepsis outcomes in children. During the initial post-facility period, mortality is high with as many children dying during this period as during the acute period of hospitalization, mostly due to recurrent illness (including infections) which are associated with malnutrition and severe acute disease. Long-term outcomes, often labelled as post-sepsis syndrome (PSS), are characterized by a lag in developmental milestones and suboptimal quality of life (QoL). While long-term outcomes have not been well characterized in resource limited settings, they are well described in high-income countries (HICs), and likely are important contributors to long-term morbidity in resource limited settings. The paucity of interventional research to improve post-discharge outcomes (short- or long-term) is a clear gap in addressing its burden. A focus on the development of improved data systems for collecting routine data, standardized definitions and terminology and a health-systems approach in research need to be prioritized during any efforts to improve outcomes during the post-sepsis phase.

Sections du résumé

OBJECTIVE OBJECTIVE
The objective of this narrative review is to outline the current epidemiology and interventional research within the context of sepsis recovery, and to provide a summary of key priorities for future work in this area.
BACKGROUND BACKGROUND
Morbidity and mortality secondary to sepsis disproportionately affects children, especially those in low- and middle-income countries (LMICs), where over 85% of global cases and deaths occur. These regions are plagued by poorly resilient health systems, widespread socio-economic deprivation and unique vulnerabilities such as malnutrition. Reducing the overall burden of sepsis will require a multi-pronged strategy that addresses all three important periods along the sepsis care continuum - pre-facility, facility and post-facility. Of these aspects, post-facility issues have been largely neglected in research, practice and policy, and are thus the focus of this review.
METHODS METHODS
Relevant data for this review was identified through a literature search using PubMed, through a review of the citations of select systematic reviews and from the personal repositories of articles collected by the authors. Data is presented within three sections. The first two sections on the short and long-term outcomes among sepsis survivors each outline the epidemiology as well as review relevant interventional research done. Where clear gaps exist, these are stated. The third section focuses on priorities for future research. This section highlights the importance of data (and data systems) and of innovative interventional approaches, as key areas to improve research of post-sepsis outcomes in children.
CONCLUSIONS CONCLUSIONS
During the initial post-facility period, mortality is high with as many children dying during this period as during the acute period of hospitalization, mostly due to recurrent illness (including infections) which are associated with malnutrition and severe acute disease. Long-term outcomes, often labelled as post-sepsis syndrome (PSS), are characterized by a lag in developmental milestones and suboptimal quality of life (QoL). While long-term outcomes have not been well characterized in resource limited settings, they are well described in high-income countries (HICs), and likely are important contributors to long-term morbidity in resource limited settings. The paucity of interventional research to improve post-discharge outcomes (short- or long-term) is a clear gap in addressing its burden. A focus on the development of improved data systems for collecting routine data, standardized definitions and terminology and a health-systems approach in research need to be prioritized during any efforts to improve outcomes during the post-sepsis phase.

Identifiants

pubmed: 34765492
doi: 10.21037/tp-20-390
pii: tp-10-10-2666
pmc: PMC8578768
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

2666-2677

Informations de copyright

2021 Translational Pediatrics. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tp-20-390). The series “Pediatric Critical Care” was commissioned by the editorial office without any funding or sponsorship. Dr. LH reports grants from Canadian Institutes of Health Research Canada Research Chair, during the conduct of the study. The authors have no other conflicts of interest to declare.

Références

Pediatrics. 2009 Mar;123(3):849-57
pubmed: 19255013
Mol Med. 2019 Dec 31;26(1):6
pubmed: 31892321
Trends Parasitol. 2020 Feb;36(2):91-97
pubmed: 31864893
Lancet. 2010 Oct 16;376(9749):1339-46
pubmed: 20934212
PLoS One. 2020 Feb 5;15(2):e0227939
pubmed: 32023265
Sci Rep. 2019 Apr 12;9(1):5981
pubmed: 30979939
Healthcare (Basel). 2018 Sep 11;6(3):
pubmed: 30208619
Pediatr Crit Care Med. 2019 Jun;20(6):568-569
pubmed: 31162349
BMC Med. 2019 Jan 28;17(1):20
pubmed: 30686268
Pediatr Crit Care Med. 2016 May;17(5):400-5
pubmed: 27043996
Nature. 2017 Aug 24;548(7668):407-412
pubmed: 28813414
Medicine (Baltimore). 2019 Mar;98(9):e14733
pubmed: 30817625
JAMA Pediatr. 2014 Oct;168(10):955-62; quiz 965-6
pubmed: 25155156
Crit Care Med. 2020 Mar;48(3):319-328
pubmed: 32058369
Pediatr Int. 2017 May;59(5):564-569
pubmed: 27935218
Glob Health Sci Pract. 2016 Sep 29;4(3):422-34
pubmed: 27628107
Lancet Glob Health. 2019 Oct;7(10):e1435-e1447
pubmed: 31537373
Lancet Glob Health. 2016 Jul;4(7):e464-73
pubmed: 27265353
Int J Clin Pract. 2018 Jun;72(6):e13211
pubmed: 29855123
Arch Phys Med Rehabil. 2020 Apr;101(4):728-729
pubmed: 31703808
Am J Respir Crit Care Med. 2015 May 15;191(10):1147-57
pubmed: 25734408
Pediatrics. 2010 Jul;126(1):e171-8
pubmed: 20547650
Cochrane Database Syst Rev. 2016 Dec 20;12:CD005436
pubmed: 27996088
Crit Care Med. 2013 Apr;41(4):1094-103
pubmed: 23385103
BMJ Open. 2017 Dec 29;7(12):e019170
pubmed: 29289941
N Engl J Med. 2017 Aug 3;377(5):414-417
pubmed: 28658587
Curr Probl Pediatr Adolesc Health Care. 2019 Jan;49(1):23-30
pubmed: 30595524
Pediatr Crit Care Med. 2017 Dec;18(12):e625-e627
pubmed: 28914721
Matern Health Neonatol Perinatol. 2017 Jul 12;3:13
pubmed: 28706729
Crit Care Med. 2020 Mar;48(3):329-337
pubmed: 32058370
BMJ Open. 2019 May 5;9(5):e028454
pubmed: 31061058
Afr Health Sci. 2016 Dec;16(4):883-891
pubmed: 28479878
Crit Care Explor. 2020 Jun 11;2(6):e0123
pubmed: 32695992
Trials. 2017 Jun 19;18(1):284
pubmed: 28629471
BMC Public Health. 2013 Oct 10;13:954
pubmed: 24112360
Pediatrics. 2019 Jan;143(1):
pubmed: 30552144
BMJ Open. 2019 May 22;9(5):e027666
pubmed: 31122993
Clin Epidemiol. 2012;4:319-25
pubmed: 23226074
BMJ Open. 2018 Dec 28;8(12):e023445
pubmed: 30593550
Nature. 2014 Jun 19;510(7505):417-21
pubmed: 24896187
BMC Med. 2019 May 21;17(1):98
pubmed: 31109328
Lancet Infect Dis. 2015 May;15(5):501-3
pubmed: 25932573
Lancet Infect Dis. 2012 Mar;12(3):191-200
pubmed: 22172305
Pediatrics. 2016 Dec;138(6):
pubmed: 27940670
Wellcome Open Res. 2020 Oct 8;5:234
pubmed: 33195820
N Engl J Med. 2020 Dec 3;383(23):2242-2254
pubmed: 33264546
Int J Equity Health. 2020 Aug 10;19(1):136
pubmed: 32778121
Disabil Rehabil. 2014;36(17):1385-94
pubmed: 24151820
Trials. 2018 Nov 6;19(1):610
pubmed: 30400934
BMJ Open. 2019 Sep 6;9(9):e029526
pubmed: 31494611
Pediatr Infect Dis J. 2019 Aug;38(8):e175-e177
pubmed: 31306401
J Perinatol. 2013 Jul;33(7):558-64
pubmed: 23328927
Lancet. 2020 Jan 18;395(10219):200-211
pubmed: 31954465
Trop Med Int Health. 2005 Nov;10(11):1114-20
pubmed: 16262736
PLoS One. 2013 Jun 25;8(6):e66698
pubmed: 23825556
Am J Phys Med Rehabil. 2015 Oct;94(10):823-8
pubmed: 26098925
CMAJ. 2017 Sep 11;189(36):E1128-E1129
pubmed: 28893874
Pediatr Crit Care Med. 2019 Jun;20(6):e274-e282
pubmed: 30946294
Front Cell Infect Microbiol. 2020 Jun 11;10:262
pubmed: 32596165
PLoS One. 2018 Aug 14;13(8):e0202334
pubmed: 30106987
Sci Rep. 2019 Oct 17;9(1):14940
pubmed: 31624288
BMC Health Serv Res. 2018 Mar 27;18(1):207
pubmed: 29580238
Phys Ther. 2019 Apr 1;99(4):396-405
pubmed: 30561749
PLoS One. 2019 Jun 20;14(6):e0214563
pubmed: 31220109
Acta Paediatr. 2014 Dec;103(12):1211-8
pubmed: 25073543
J Glob Health. 2017 Jun;7(1):011002
pubmed: 28685048
Int J Qual Health Care. 2019 Apr 1;31(3):191-198
pubmed: 29924325
BMC Med Res Methodol. 2019 May 7;19(1):92
pubmed: 31064323
Front Public Health. 2019 Nov 15;7:341
pubmed: 31803706
JAMA Pediatr. 2018 Mar 1;172(3):213-214
pubmed: 29379956
JAMA Pediatr. 2019 Apr 1;173(4):352-362
pubmed: 30742207

Auteurs

Matthew O Wiens (MO)

Center for International Child Health, BC Children's Hospital, Vancouver, BC, Canada.
Department of Anesthesia, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada.
Mbarara University of Science and Technology, Mbarara, Uganda.

Niranjan Kissoon (N)

Center for International Child Health, BC Children's Hospital, Vancouver, BC, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.

Liisa Holsti (L)

Department of Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada.

Classifications MeSH